Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Lianchun Xiao"'
Autor:
Kanwal Pratap Singh Raghav, Li Liang, Robert A. Wolff, J. Morris, Bryan K. Kee, Imad Shureiqi, Van K. Morris, Thibault Mazard, Lianchun Xiao, Funda Meric-Bernstam, Gordon B. Mills, James L. Abbruzzese, Cathy Eng, Kenna Rael Shaw, Eduardo Vilar, Scott Kopetz, Michael J. Overman, Arvind Dasari, Rachna T. Shroff, David R. Fogelman, Dipen M. Maru, Stanley R. Hamilton
Publikováno v:
Annals of Oncology
Annals of Oncology, Elsevier, 2016, 27 (6), pp.1068-1074. ⟨10.1093/annonc/mdw073⟩
Annals of Oncology, Elsevier, 2016, 27 (6), pp.1068-1074. ⟨10.1093/annonc/mdw073⟩
BACKGROUND: Incorporation of multiple enrichment biomarkers into prospective clinical trials is an active area of investigation, but the factors that determine clinical trial enrollment following a molecular prescreening program have not been assesse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e904e3ae1567c32e922a118ca1ebc2b1
https://europepmc.org/articles/PMC6276928/
https://europepmc.org/articles/PMC6276928/
Autor:
John M. Vierling, Sunil Krishnan, Robert A. Wolff, Prasun Jalal, James L. Abbruzzese, Jeffrey S. Morris, Ahmed Kaseb, Steven A. Curley, Jean Nicolas Vauthey, Claudius Conrad, Hesham M. Hassabo, Thomas A. Aloia, Sheree Cheung, Manal M. Hassan, Young Kwang Chae, Michael J. Wallace, Asif Rashid, Kanwal Pratap Singh Raghav, Lianchun Xiao, Ju Seog Lee
Publikováno v:
JNCI Journal of the National Cancer Institute
Background Child-Turcotte-Pugh (CTP) score is the standard tool to assess hepatic reserve in hepatocellular carcinoma (HCC), and CTP-A is the classic group for active therapy. However, CTP stratification accuracy has been questioned. We hypothesized
Autor:
Manoop S. Bhutani, Jaffer A. Ajani, Akihiro Suzuki, Stephen G. Swisher, Peter F. Thall, Lianchun Xiao, Takashi Taketa, A. P. Phan, Wayne L. Hofstetter, David C. Rice, Garrett L. Walsh, Jack A. Roth, A. Halpin, Ara A. Vaporciyan, Zhongxing Liao, Dipen M. Maru, Ahmed Eid, Jeffrey H. Lee, Ritsuko Komaki, James C. Yao
Background The contribution of induction chemotherapy (IC) before preoperative chemoradiation for esophageal cancer (EC) is not known. We hypothesized that IC would increase the rate of pathologic complete response (pathCR). Methods Trimodality-eligi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c427213241a986ace8ec847f3ca7fc3
https://europepmc.org/articles/PMC3937600/
https://europepmc.org/articles/PMC3937600/